Katalog GES



Mental Health Policy and Psychotropic Drugs

The pace of innovation in psychotropic drugs has been rapid over the past 15 years. There also have been unprecedented increases in spending on prescription drugs generally and psychotropic medications specifically. Psychotropic medications are playing a more central role in treatment. They also... Full description

1st Person: Frank, Richard G.
Additional Persons: Conti, Rena M. verfasserin; Goldman, Howard H. verfasserin
Source: in The Milbank quarterly : a journal of public health and health care policy Vol. 83, No. 2 (2005), p. 271-298
More Articles
Type of Publication: Article
Language: English
Published: 2005
Keywords: research-article
Psychotropic drugs
Mental health treatment
Mental health policy
Managed behavioral healthcare
Online: Volltext
  Search for full text
LEADER 01975nma a2200337 c 4500
001 JST058170049
003 DE-601
005 20180602225117.0
007 cr uuu---uuuuu
008 150325s2005 000 0 eng d
024 8 |a 30045615 
035 |a 30045615 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Frank, Richard G. 
245 1 0 |a Mental Health Policy and Psychotropic Drugs  |h Elektronische Ressource 
300 |a Online-Ressource 
500 |a Copyright: Copyright 2005 Milbank Memorial Fund 
520 |a The pace of innovation in psychotropic drugs has been rapid over the past 15 years. There also have been unprecedented increases in spending on prescription drugs generally and psychotropic medications specifically. Psychotropic medications are playing a more central role in treatment. They also are receiving close scrutiny from health insurers, state budget makers, and ordinary citizens. Public policy actions regarding prescription drugs have the potential to significantly affect clinical care for mental disorders, the costs of this care to individuals and society at large, and the prospects for future scientific advances. This article outlines the policy issues related to psychotropic drugs with respect to their role in determining access to mental health treatment and the cost and quality of mental health care. 
653 |a research-article 
653 |a Psychotropic drugs 
653 |a Mental health treatment 
653 |a Mental health policy 
653 |a Managed behavioral healthcare 
700 1 |a Conti, Rena M.  |e verfasserin  |4 aut 
700 1 |a Goldman, Howard H.  |e verfasserin  |4 aut 
773 0 8 |i in  |t The Milbank quarterly : a journal of public health and health care policy  |d Oxford : Wiley-Blackwell  |g Vol. 83, No. 2 (2005), p. 271-298  |q 83:2<271-298  |w (DE-601)JST058162925  |x 0887-378X 
856 4 1 |u https://www.jstor.org/stable/30045615  |3 Volltext 
912 |a GBV_JSTOR 
951 |a AR 
952 |d 83  |j 2005  |e 2  |h 271-298 

Similar Items

Cannot find similar records

Library Services

Search Options

Quick links

Orientation